Q2 2020 Holdings
Filed 2020-08-14 | 48 holdings | $57.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Codexis Inc(CDXS) | COM | 192005106 | $16.1M | 1,400,000 | 27.9% |
| Celldex Therapeutics Inc(CLDX) | COM NEW | 15117B202 | $13.9M | 1,071,000 | 24.1% |
| Crinetics Pharmaceuticals Inc(CRNX) | COM | 22663K107 | $7.6M | 435,200 | 13.2% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $7.1M | 303,050 | 12.4% |
| Catalyst Pharmaceuticals Inc(CPRX) | COM | 14888U101 | $5.3M | 1,155,000 | 9.2% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $3.3M | 471,600 | 5.7% |
| Cardiff Oncology Inc(CRDF) | COM | 14147L108 | $3.0M | 590,000 | 5.1% |
| Autolus Therapeutics PLC(AUTL) | SPONSORED ADS | 05280R100 | $962.0K | 60,000 | 1.7% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $64.8K | 2,208,472 | 0.1% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $49.8K | 5,984,200 | 0.1% |
| Neoleukin Therapeutics Inc | COM | 64049K104 | $23.2K | 1,400,000 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $20.8K | 361,600 | 0.0% |
| Eton Pharmaceuticals Inc(ETON) | COM | 29772L108 | $19.8K | 3,640,000 | 0.0% |
| Aptose Biosciences Inc | COM NEW | 03835T200 | $19.8K | 3,130,000 | 0.0% |
| Stereotaxis Inc(STXS) | COM NEW | 85916J409 | $15.7K | 3,511,500 | 0.0% |
| Eidos Therapeutics Inc(EIDXGBP) | COM | 28249H104 | $14.6K | 315,550 | 0.0% |
| Harrow Health Inc(HROW) | COM | 415858109 | $14.1K | 2,710,000 | 0.0% |
| Myovant Sciences LTD | COM | G637AM102 | $14.1K | 682,500 | 0.0% |
| Macrogenics Inc(MGNX) | COM | 556099109 | $14.0K | 501,000 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $13.1K | 222,000 | 0.0% |
| Avenue Therapeutics Inc | COM NEW | 05360L205 | $11.1K | 1,035,000 | 0.0% |
| Odonate Therapeutics Inc | COM | 676079106 | $10.6K | 250,000 | 0.0% |
| Fortress Biotech Inc | COM | 34960Q109 | $10.3K | 3,830,000 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $8.9K | 456,600 | 0.0% |
| Kiniksa Pharmaceuticals LTD | COM CL A | G5269C101 | $8.8K | 344,500 | 0.0% |
| Cerecor Inc | COM | 15671L109 | $8.8K | 3,372,500 | 0.0% |
| Vaxcyte(QURE) | SHS | N90064101 | $8.5K | 270,400 | 0.0% |
| Biohaven Pharmaceutical Hldg(BHVN) | COM | G11196105 | $8.4K | 114,350 | 0.0% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $8.2K | 415,380 | 0.0% |
| Molecular Templates Inc | COM | 608550109 | $6.8K | 495,000 | 0.0% |
| Tricida Inc(1T7) | COM | 89610F101 | $6.5K | 238,300 | 0.0% |
| Chimerix Inc(CMRXEUR) | COM | 16934W106 | $6.5K | 2,105,000 | 0.0% |
| MEI Pharma Inc | COM NEW | 55279B202 | $6.4K | 1,556,000 | 0.0% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $5.7K | 146,000 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $5.6K | 461,500 | 0.0% |
| Bioxcel Therapeutics Inc(BTAIEUR) | COM | 09075P105 | $5.0K | 94,000 | 0.0% |
| Edap TMS SA(EDA) | SPONSORED ADR | 268311107 | $4.6K | 1,878,500 | 0.0% |
| Kala Pharmaceuticals Inc | COM | 483119103 | $3.8K | 361,000 | 0.0% |
| Cidara Therapeutics Inc | COM | 171757107 | $3.6K | 970,664 | 0.0% |
| Liquidia Techologies Inc(LQDA) | COM | 53635D202 | $3.4K | 400,000 | 0.0% |
| Tela BIO Inc(TELA) | COM | 872381108 | $3.2K | 250,000 | 0.0% |
| Amarin Corp PLC | SPONSORED ADR | 023111206 | $3.1K | 455,000 | 0.0% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $2.5K | 960,000 | 0.0% |
| Fennec Pharmaceuticals Inc(FENC) | COM | 31447P100 | $1.4K | 171,000 | 0.0% |
| Essa Pharma Inc(EPIEUR) | COM NEW | 29668H708 | $1.1K | 175,000 | 0.0% |
| Assertio Holdings Inc | COM | 04546C106 | $754 | 880,000 | 0.0% |
| Magenta Therapeutics Inc | COM | 55910K108 | $385 | 51,225 | 0.0% |
| Biolinerx LTD | SPONSORED ADS | 09071M205 | $29 | 16,667 | 0.0% |